Preclinical Alzheimer's disease and longitudinal driving decline

Links between preclinical Alzheimer's disease (AD) and driving difficulty onset would support the use of driving performance as an outcome in primary and secondary prevention trials among older adults (OAs). We examined whether AD biomarkers predicted the onset of driving difficulties among OAs.

• Publication year

  2016

• Venue

  Alzheimer's & Dementia

• Publication date

  2016-12-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.trci.2016.11.006PMID 28435853PMCID 5396459
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Video Feedback Intervention to Enhance the Safety of Older Drivers With Cognitive Impairment

  2017cited by this paper
• Amyloid Imaging, Cerebrospinal Fluid Biomarkers Predict Driving Performance Among Cognitively Normal Individuals

  2017influential reference
• Creating a driving profile for older adults using GPS devices and naturalistic driving methodology

  2016cited by this paper
• Development and interval testing of a naturalistic driving methodology to evaluate driving behavior in clinical research

  2016cited by this paper
• Brain amyloid in preclinical Alzheimer's disease is associated with increased driving risk

  2016cited by this paper
• A Systematic Review and Meta-Analysis of On-Road Simulator and Cognitive Driving Assessment in Alzheimer’s Disease and Mild Cognitive Impairment

  2016cited by this paper
• Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease

  2015cited by this paper
• Assessing cognition and function in Alzheimer's disease clinical trials: Do we have the right tools?

  2014cited by this paper
• The relation between performance in on-road driving, cognitive screening and driving simulator in older healthy drivers

  2014cited by this paper
• Researchers test strategies to prevent Alzheimer disease.

  2014cited by this paper
• Naturalistic Distraction and Driving Safety in Older Drivers

  2013cited by this paper
• Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study.

  2013cited by this paper
• Regulatory innovation and drug development for early-stage Alzheimer's disease.

  2013cited by this paper
• Exploration of 100 commonly used drugs and supplements on cognition in older adults

  2013cited by this paper
• Clinical and biomarker changes in dominantly inherited Alzheimer's disease.

  2012cited by this paper
• Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease.

  2012cited by this paper
• Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011cited by this paper
• Assessment of cognition in early dementia

  2011cited by this paper
• Predicting Road Test Performance in Drivers with Dementia

  2011influential reference
• Amyloid imaging as a biomarker for cerebral β-amyloidosis and risk prediction for Alzheimer dementia.

  2011cited by this paper
• Incidence and Total Lifetime Costs of Motor Vehicle–Related Fatal and Nonfatal Injury by Road User Type, United States, 2005

  2010cited by this paper
• How does dementia affect driving in older patients?

  2010cited by this paper
• Stability of the Clinical Dementia Rating, 1979-2007.

  2009cited by this paper
• Early risk assessment for Alzheimer's disease

  2009cited by this paper
• Cerebrospinal fluid biomarkers and rate of cognitive decline in very mild dementia of the Alzheimer type.

  2009cited by this paper
• Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support

  2009cited by this paper
• The Alzheimer's Disease Centers' Uniform Data Set (UDS): The Neuropsychologic Test Battery

  2009cited by this paper
• Mild neuritic changes are increased in the brains of fatally injured older motor vehicle drivers.

  2007cited by this paper
• Collisions Involving Senior Drivers: High-Risk Conditions and Locations

  2006cited by this paper
• Presalvage prostate‐specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy

  2006cited by this paper
• Potential antecedent marker of Alzheimer disease

  2006cited by this paper
• Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans

  2006cited by this paper
• [11C]PIB in a nondemented population

  2006cited by this paper
• Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B

  2004influential reference
• Longitudinal Driving Performance in Early‐Stage Dementia of the Alzheimer Type

  2003cited by this paper
• National Highway Traffic Safety Administration

  2002cited by this paper
• Neurotechnique Whole Brain Segmentation: Automated Labeling of Neuroanatomical Structures in the Human Brain

  2002cited by this paper
• Linear Mixed Models for Longitudinal Data

  2001cited by this paper
• Older drivers and cataract: driving habits and crash risk.

  1999influential reference
• Controlling the false discovery rate: a practical and powerful approach to multiple testing

  1995cited by this paper
• The Clinical Dementia Rating (CDR)

  1993cited by this paper
• Alzheimer’s Dementia

  1985cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper
• Regression Models and Life-Tables

  year unknowncited by this paper

• White Matter Hyperintensity Burden and Decline in Driving Performance Among Older Adults

  2026cites this paper
• Sensorimotor function as an early marker of cognitive decline and alzheimer's biomarker burden.

  2025cites this paper
• Driving into diagnosis: Leveraging high-resolution telematics and sensorimotor profiling to identify preclinical Alzheimer's disease

  2025cites this paper
• A Machine Learning and Explainable AI Framework for Detecting Preclinical Alzheimer’s Disease from Naturalistic Driving Behavior

  2025cites this paper
• Association of Daily Driving Behaviors With Mild Cognitive Impairment in Older Adults Followed Over 10 Years.

  2025cites this paper
• Multi‐modal machine learning for predicting amyloid positivity using on‐ramp driving

  2025cites this paper
• A combined naturalistic driving, clinical, and neurobehavioral data set for investigating aging and dementia

  2025cites this paper
• Integrating Machine Learning and Environmental and Genetic Risk Factors for the Early Detection of Preclinical Alzheimer's Disease.

  2025cites this paper
• Slowed Driving Reaction Time in Preclinical Alzheimer’s Disease

  2025cites this paper
• Digital Neuropsychology beyond Computerized Cognitive Assessment: Applications of Novel Digital Technologies.

  2024cites this paper
• Enhancing road safety: In-vehicle sensor analysis of cognitive impairment in older drivers

  2024cites this paper
• Impact of cognitive impairment on driving behaviour and route choices of older drivers: a real-world driving study

  2024cites this paper
• Predicting Driving Cessation Among Cognitively Normal Older Drivers

  2024cites this paper
• Falls and Alzheimer Disease

  2024cites this paper
• Detecting mild cognitive impairment and dementia in older adults using naturalistic driving data and interaction-based classification from influence score

  2023cites this paper
• Individuals learning to drive solo before age 18 have superior spatial navigation ability compared with those who learn later

  2023cites this paper
• Medication and Road Test Performance Among Cognitively Healthy Older Adults

  2023cites this paper
• Associations Between Plasma, Imaging, and Cerebrospinal Fluid Biomarkers with Driving Behavior and Cognitive Tests: Implications for Biomarker Usefulness

  2023cites this paper
• Differential Impacts of Road Diets on Driving Behavior among Older Adults with and without Preclinical Alzheimer's Pathology.

  2023cites this paper
• Driving Automation for Older Adults with Preclinical Alzheimer’s Disease

  2023influential citation
• Matching science to reality: how to deploy a participant-driven digital brain health platform

  2023cites this paper
• Everyday Driving and Plasma Biomarkers in Alzheimer’s Disease: Leveraging Artificial Intelligence to Expand Our Diagnostic Toolkit

  2023cites this paper
• Determinants of physical activity engagement in older adults

  2023cites this paper
• Association between mandatory cognitive testing for license renewal and motor vehicle collisions and road injuries

  2023cites this paper
• Driving Performance of Experienced Young Adult Drivers with and without Autism Spectrum Disorder While Listening to Music on Two Scenarios: Hazards versus Wayfinding

  2022cites this paper
• Predicting driving decline and assessing crash risk in a globally aging population

  2022cites this paper
• Adverse driving behaviors are associated with sleep apnea severity and age in cognitively normal older adults at risk for Alzheimer's disease.

  2022cites this paper
• Improving Our Understanding of Driving Changes in Preclinical and Early Symptomatic Alzheimer’s Disease: The Role of Naturalistic Driving Studies

  2022cites this paper
• Driving Ability Evaluation and Rehabilitation for People With Alzheimer’s Disease and Related Dementias

  2022cites this paper
• Driving assessment in preclinical Alzheimer’s disease: progress to date and the path forward

  2022cites this paper
• Adverse driving behaviors increase over time as a function of preclinical Alzheimer's disease biomarkers

  2022cites this paper
• Cognitive and brain reserve predict decline in adverse driving behaviors among cognitively normal older adults

  2022cites this paper
• Using Naturalistic Driving Data to Predict Mild Cognitive Impairment and Dementia: Preliminary Findings from the Longitudinal Research on Aging Drivers (LongROAD) Study

  2021cites this paper
• A whole‐brain functional connectivity model of Alzheimer's disease pathology

  2021cites this paper
• Novel Methodology for Alzheimer's Disease Biomarker Identification in Plasma using Hyperspectral Microscopy

  2020cites this paper
• Cognition and Daily Functioning: Results from the Hispanic Community Health Study/Study of Latinos (SOL) and Study of Latinos-Investigation of Neurocognitive Aging (SOL-INCA)

  2020cites this paper
• Recruitment of African American and Non-Hispanic White Older Adults for Alzheimer Disease Research Via Traditional and Social Media: a Case Study

  2020cites this paper
• The Road to Recovery: A Pilot Study of Driving Behaviors Following Antibody-Mediated Encephalitis

  2020cites this paper
• The Role of Eye Tracking Technology in Assessing Older Driver Safety

  2020cites this paper
• Heart Failure and Fitness-to-Drive: Do We Know When to Say When?

  2020cites this paper
• Driving habits and reaction times on a driving simulation in older drivers with chronic heart failure.

  2020cites this paper
• Driving cessation in people with dementia

  2020cites this paper
• Driving habits and reaction times on a driving simulation in older drivers with chronic heart failure.

  2020cites this paper
• Identifying Preclinical Alzheimer’s Disease Using Everyday Driving Behavior: Proof of Concept

  2020influential citation
• Inferring Drivers’ Visual Focus Attention Through Head-Mounted Inertial Sensors

  2019cites this paper
• CZYH Alleviates β-Amyloid-Induced Cognitive Impairment and Inflammation Response via Modulation of JNK and NF-κB Pathway in Rats

  2019cites this paper
• Differences in Driving Outcomes Among Cognitively Normal African American and Caucasian Older Adults

  2019cites this paper
• Older Adults’ Expectations about Mortality, Driving Life and Years Left without Driving

  2019cites this paper
• Pilot study of a new road test to assess cognitive fitness to drive

  2019cites this paper
• A 2.5-Year Longitudinal Assessment of Naturalistic Driving in Preclinical Alzheimer’s Disease

  2019cites this paper
• Alzheimer Disease Biomarkers and Driving in Clinically Normal Older Adults: Role of Spatial Navigation Abilities

  2018cites this paper
• Icariside II ameliorates ibotenic acid-induced cognitive impairment and apoptotic response via modulation of MAPK pathway in rats.

  2018cites this paper
• Depression and Alzheimer’s Disease Biomarkers Predict Driving Decline

  2018cites this paper
• Driving Status and Transportation Disadvantage Among Medicare Beneficiaries

  2018cites this paper
• Using the A/T/N Framework to Examine Driving in Preclinical Alzheimer’s Disease

  2018cites this paper
• Cognitive Decline and Older Driver Crash Risk

  2018cites this paper
• Driving cessation over a 24‐year period: Dementia severity and cerebrospinal fluid biomarkers

  2018cites this paper
• Self-awareness of Driving Ability in the Healthy Elderly and Patients With Mild Cognitive Impairment (MCI)

  2018cites this paper
• Tau and Amyloid Positron Emission Tomography Imaging Predict Driving Performance Among Older Adults with and without Preclinical Alzheimer’s Disease

  2017cites this paper
• Neuropsychiatric Symptoms and Alzheimer’s Disease Biomarkers Predict Driving Decline: Brief Report

  2017influential citation